tiprankstipranks
Trending News
More News >

Mark T Iwicki Insider Profile

11 Followers
Mark T Iwicki, Director at Aimmune Therapeutics, holds 0.00 shares in Merus (Ticker: MRUS), holds 0.00 shares in Akero Therapeutics (Ticker: AKRO), holds 103.54K shares in KALA BIO (Ticker: KALA).
tipranks
Mark T Iwicki

Mark T Iwicki
Aimmune Therapeutics (AIMT)
Director

Ranked #51,282 out of 105,390 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+1.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$769K
91.39%
8.61%
0.00%
0.00%
0.00% Others
A breakdown of Mark T Iwicki's holdings

Insider Roles

Pulmatrix
(PULM)
Director
KALA BIO
(KALA)
Director
Merus
(MRUS)
Director
Jade Biosciences
(JBIO)
Director
+2 other positions
Roles that Mark T Iwicki holds in companies

Most Profitable Insider Trade

Stock:
KALA BIO
(KALA)
Rating:Informative Sell
Date:Oct 24, 2025 - Today
Return:+21.70%
The most profitable trade made by Mark T Iwicki

Mark T Iwicki's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AIMT
Aimmune Therapeutics
Oct 14, 2020
Uninformative Sell
270.48K
$0.00
KALA BIO
Oct 24, 2025
Director
Informative Sell
125.46K
$66.27K
Pulmatrix
Apr 05, 2018
Director
Uninformative Buy
$703.03K
AKRO
Akero Therapeutics
Dec 09, 2025
Uninformative Sell
$0.00
Merus
Dec 12, 2025
Director
Uninformative Sell
7.14M
$0.00
Jade Biosciences
Director
THRD
Third Harmonic Bio, Inc.
Q32 Bio
Director
Inhibikase Therapeutics
CEO, Director
List of latest transactions for each holding click on a transaction to see Mark T Iwicki's performance on stock

Mark T Iwicki insider profile FAQ

What is the percentage of profitable transactions made by Mark T Iwicki?
The percentage of profitable transactions made by Mark T Iwicki is 50%.
    What is the average return per transaction made by Mark T Iwicki?
    The average return per transaction made by Mark T Iwicki is 1.70%.
      What stocks does Mark T Iwicki hold?
      Mark T Iwicki holds: AIMT, KALA, PULM, AKRO, MRUS, JBIO, THRD, QTTB, IKT stocks.
        What was Mark T Iwicki’s latest transaction?
        Mark T Iwicki latest transaction was an Uninformative Sell of $7.14M.
          What was Mark T Iwicki's most profitable transaction?
          Mark T Iwicki’s most profitable transaction was an Informative Sell of KALA stock on October 24, 2025. The return on the trade was 21.70%.
            What is Mark T Iwicki's role in Aimmune Therapeutics?
            Mark T Iwicki's role in Aimmune Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.